Dr. Holliday is on Doximity
As a Doximity member you'll join over two million verified healthcare professionals in a private, secure network.
- Gain access to free telehealth tools, such as our “call shielding” and one-way patient texting.
- Connect with colleagues in the same hospital or clinic.
- Read the latest clinical news, personalized to your specialty.
Office
1020 Hitt St
Columbia, MO 65212Phone+1 573-882-8788Fax+1 573-882-3131
Summary
- Dr. Zachary Holliday is a pulmonologist in Columbia, MO and is affiliated with multiple hospitals in the area, including University Hospital and Harry S. Truman Memorial Veterans' Hospital. He received his medical degree from University of Missouri-Columbia School of Medicine and has been in practice 5 years. He specializes in critical care medicine. He has 9 publications and over 100 citings.
Education & Training
University of Iowa Hospitals and ClinicsResidency, Internal Medicine, 2012 - 2015
University of Missouri-ColumbiaResidency, Internal Medicine, 2012 - 2015
University of Missouri-Columbia School of MedicineClass of 2012- University of Iowa Hospitals and ClinicsFellowship, Pulmonary Disease and Critical Care Medicine
Certifications & Licensure
MO State Medical License 2015 - 2025
IA State Medical License 2016 - 2020- American Board of Internal Medicine Internal Medicine
- American Board of Internal Medicine Critical Care Medicine
- American Board of Internal Medicine Pulmonary Disease
Publications & Presentations
PubMed
- 35 citationsNon-Randomized Trial of Dornase Alfa for Acute Respiratory Distress Syndrome Secondary to Covid-19.Zachary M. Holliday, Alexander P. Earhart, Mohammed Alnijoumi, Armin Krvavac, Lee-Ann H. Allen
Frontiers in Immunology. 2021-10-20 - 48 citationsOral probiotics in coronavirus disease 2019: connecting the gut–lung axis to viral pathogenesis, inflammation, secondary infection and clinical trialsPiyush Baindara, Ranadhir Chakraborty, Zachary M. Holliday, Santi M. Mandal, Adam G. Schrum
New Microbes and New Infections. 2021-03-01 - 36 citationsConsideration of dornase alfa for the treatment of severe COVID-19 acute respiratory distress syndrome.Alexander P. Earhart, Zachary M. Holliday, H.V. Hofmann, Adam G. Schrum
New Microbes and New Infections. 2020-04-30
Viewing the full profile is available to verified healthcare professionals only.
Find your profile and take control of your online presence:
